Veklury Coupon & Prices
Get notified when Veklury medication is added to NiceRxGet Started Now
Secure: Your personal and medical information is safe with us
Convenient: Your medication is delivered straight to your door
Ongoing refills: Your medication is refilled automatically
Is NiceRx a Veklury coupon provider?
At NiceRx, we help eligible individuals access patient assistance programs. This means that we are not a Veklury coupon, a Veklury discount card, or a Veklury copay card provider. We do not offer any medication trial offers or free Veklury samples.
Veklury patient assistance program
Patient assistance programs are typically sponsored by pharmaceutical companies and provide free or discounted medications to individuals with low income who are uninsured or under-insured and meet the eligibility criteria that vary by program. There are currently no known patient assistance programs for this medication.
Can NiceRx help me get Veklury cheaper if I have insurance?
We may be able to help you if you have insurance, including if your insurance company will not pay for your Veklury medication, or if you have a high copay or coinsurance responsibility. We may even be able to assist if you do not have insurance. Please fill in our enrollment application to find out more.
How much does Veklury cost without insurance?
Veklury costs without insurance will vary depending on how much you buy and the retailer you buy it from. As a guide, Veklury intravenous powder for injection of 100 mg will typically cost around $560 for 1 powder for injection.
How much does Veklury cost with insurance?
The copay of Veklury will vary in line with the specific terms of your healthcare plan. For further details about what you may need to pay, your insurance provider or pharmacist will be able to calculate the copay costs with your current insurance.
What is Veklury?
Veklury is an FDA (U.S. Food and Drug Administration) approved medication manufactured by Gilead Sciences, Inc. Veklury is a SARS-CoV-2 nucleotide analog RNA polymerase inhibitor with FDA approval to be used in adults and pediatric patients 12 years of age and older to treat coronavirus disease 2019 requiring hospitalization.
Veklury has also been granted Emergency Use Authorization (EUA) for the treatment of non-hospitalized adults and non-hospitalized patients younger than 12 years of age who are at high risk of disease progression to severe COVID-19, including hospitalization or death. In doing so, Veklury may be administered in qualified outpatient settings.
What doses of Veklury are available?
Veklury is available as a lyophilized powder, in a single-dose vial for injection, in the following doses: 100 mg/20 mL (5 mg/mL).
Carry out renal and hepatic tests and assess prothrombin time during and before initiating treatment. The recommended dose in adults and pediatric patients 12 years of age and older, weighing at least 40 kg is a single loading dose of 200 mg on Day 1, then once-daily doses of 100 mg from Day 2.
The total treatment duration is 5 days for patients not requiring invasive mechanical ventilation and/or ECMO. Treatment may be extended for another 5 days in patients that do not show improvement. For patients requiring invasive mechanical ventilation and/or ECMO, the recommended total treatment duration is 10 days. High-risk non-hospitalized patients may receive Veklury via intravenous infusion for a total of 3 days for the treatment of mild-to-moderate COVID-19 disease.
Please read the full prescribing information, and the labeling provided, and always speak with your healthcare provider about any changes to your dose so they can monitor and evaluate your condition.
Veklury active ingredients
Veklury contains remdesivir as the active ingredient. It is a viral RNA polymerase inhibitor.
Veklury side effects
The most common side effects of Veklury in clinical trials compared to placebo include:
- Increase in liver enzymes – ALT and AST
In rare instances, Veklury can cause more serious side effects. These can include:
- Hypersensitivity reactions
- Increased risk of transaminase elevations
- Risk of reduced antiviral activity when coadministered with chloroquine phosphate or hydroxychloroquine sulfate
Your doctor will assess the benefits of using Veklury against your risk of side effects. Patients are encouraged to report negative side effects or adverse reactions of Veklury to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Veklury drug interactions
Veklury can interact with other medications. These include:
- Chloroquine phosphate
- Hydroxychloroquine sulfate
This list is not exhaustive and other prescription drugs may interact with Veklury.
You should not use Veklury if you:
- Have had a hypersensitivity reaction to the active ingredient remdesivir
- Have had an allergic reaction to any of the other ingredients in Veklury
Talk to your doctor before using Veklury if you:
- Are taking any of the medications that could interact with Veklury
- Have liver disease
- Have renal impairment
- Are pregnant or are planning to become pregnant
- Are breastfeeding or are planning to breastfeed
Veklury is the trademark brand name for remdesivir manufactured by Gilead Sciences, Inc. A generic version of remdesivir is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Veklury savings through NiceRx.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.